BeStock  
Stocks › Biotechnology › KRYS

Krystal Biotech KRYS

US equityMarket cap rank #1486Biotechnology
$308.89 −$6.93 (-2.19%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $308.85 -0.01%
Open$313.38
Prev close$315.82
Day range$308.22 – $321.27
Volume286.7K
Market cap$9.15B
P/E (TTM)42.0
Dividend yield–

Analyst view

ConsensusBuy
Analysts6
Average target$393.17+27.3% vs. price
  • Buy 100%
Low $361.00Now $308.89Avg $393.17High $441.00

Recent rating changes

The last 20 actions on file set price targets from $361.00 to $441.00, averaging $395.72.

DateFirmRatingTarget
6 Nov 2026 RBC Capital BUY $375.00
3 Nov 2026 TD Cowen BUY $380.00
3 Nov 2026 Citi BUY $412.00
2 Nov 2026 BofA Securities BUY $390.00
2 Nov 2026 Citi BUY $412.00
2 Nov 2026 H.C. Wainwright BUY $361.00
2 Nov 2026 RBC Capital BUY $375.00
21 Oct 2026 TD Cowen BUY $403.00
16 Oct 2026 Citi BUY $416.00
15 Oct 2026 Citi BUY $416.00
15 Oct 2026 H.C. Wainwright BUY $361.00
8 Oct 2026 RBC Capital BUY $400.00
24 Sep 2026 Goldman Sachs BUY $441.00
21 Sep 2026 BofA Securities BUY $400.00
14 Aug 2026 RBC Capital BUY $400.00
11 Aug 2026 Wolfe Research HOLD –
4 Aug 2026 Citi BUY $386.00
3 Aug 2026 TD Cowen BUY $403.00
3 Aug 2026 William Blair BUY –
3 Aug 2026 BofA Securities BUY $392.00

Discussion

No comments yet — be the first to weigh in on KRYS.

Sign in to join the discussion.

Scroll to Top